CN114544841A - 一种采用高效液相色谱法测定肺炎球菌多糖-蛋白结合疫苗中dmap残留量的方法 - Google Patents
一种采用高效液相色谱法测定肺炎球菌多糖-蛋白结合疫苗中dmap残留量的方法 Download PDFInfo
- Publication number
- CN114544841A CN114544841A CN202011325866.1A CN202011325866A CN114544841A CN 114544841 A CN114544841 A CN 114544841A CN 202011325866 A CN202011325866 A CN 202011325866A CN 114544841 A CN114544841 A CN 114544841A
- Authority
- CN
- China
- Prior art keywords
- dmap
- solution
- pneumococcal polysaccharide
- high performance
- performance liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 title claims abstract description 144
- 229960000549 4-dimethylaminophenol Drugs 0.000 title claims abstract description 72
- 238000000034 method Methods 0.000 title claims abstract description 35
- 238000004128 high performance liquid chromatography Methods 0.000 title claims abstract description 25
- 229940001442 combination vaccine Drugs 0.000 title claims abstract description 6
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 title abstract description 4
- 229940113088 dimethylacetamide Drugs 0.000 title abstract description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims abstract description 49
- 239000000243 solution Substances 0.000 claims abstract description 34
- 238000001514 detection method Methods 0.000 claims abstract description 19
- 108010060123 Conjugate Vaccines Proteins 0.000 claims abstract description 15
- 229940031670 conjugate vaccine Drugs 0.000 claims abstract description 15
- REFMEZARFCPESH-UHFFFAOYSA-M sodium;heptane-1-sulfonate Chemical compound [Na+].CCCCCCCS([O-])(=O)=O REFMEZARFCPESH-UHFFFAOYSA-M 0.000 claims abstract description 13
- 239000011259 mixed solution Substances 0.000 claims abstract description 5
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 27
- 150000004676 glycans Chemical class 0.000 claims description 23
- 229920001282 polysaccharide Polymers 0.000 claims description 23
- 239000005017 polysaccharide Substances 0.000 claims description 23
- 238000002360 preparation method Methods 0.000 claims description 16
- 238000003756 stirring Methods 0.000 claims description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- 108090000623 proteins and genes Proteins 0.000 claims description 12
- 102000004169 proteins and genes Human genes 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 229960005486 vaccine Drugs 0.000 claims description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 8
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 8
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 7
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 6
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims description 6
- 238000005070 sampling Methods 0.000 claims description 6
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 4
- 229960003964 deoxycholic acid Drugs 0.000 claims description 4
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 claims description 4
- 108010071134 CRM197 (non-toxic variant of diphtheria toxin) Proteins 0.000 claims description 3
- 239000005457 ice water Substances 0.000 claims description 3
- 239000013067 intermediate product Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 239000000047 product Substances 0.000 claims description 3
- 239000012460 protein solution Substances 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 239000012085 test solution Substances 0.000 claims description 3
- 239000012086 standard solution Substances 0.000 claims description 2
- 230000014759 maintenance of location Effects 0.000 abstract description 8
- 239000002904 solvent Substances 0.000 abstract description 5
- 239000012535 impurity Substances 0.000 abstract description 3
- 238000004190 ion pair chromatography Methods 0.000 abstract description 3
- 238000001994 activation Methods 0.000 description 9
- 230000004913 activation Effects 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 230000007246 mechanism Effects 0.000 description 7
- 239000011550 stock solution Substances 0.000 description 6
- 239000000427 antigen Substances 0.000 description 5
- 102000036639 antigens Human genes 0.000 description 5
- 108091007433 antigens Proteins 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 210000001744 T-lymphocyte Anatomy 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 239000012224 working solution Substances 0.000 description 3
- -1 1-cyano-4-dimethylaminopyridine boron Chemical compound 0.000 description 2
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 2
- 239000005695 Ammonium acetate Substances 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- 229940043376 ammonium acetate Drugs 0.000 description 2
- 235000019257 ammonium acetate Nutrition 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 125000004093 cyano group Chemical group *C#N 0.000 description 2
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 241000606768 Haemophilus influenzae Species 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 235000009430 Thespesia populnea Nutrition 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- 239000012490 blank solution Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 229940047650 haemophilus influenzae Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 229940031937 polysaccharide vaccine Drugs 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000004454 trace mineral analysis Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
- G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
- G01N2030/8831—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving peptides or proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
- G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
- G01N2030/8836—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving saccharides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011325866.1A CN114544841A (zh) | 2020-11-24 | 2020-11-24 | 一种采用高效液相色谱法测定肺炎球菌多糖-蛋白结合疫苗中dmap残留量的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011325866.1A CN114544841A (zh) | 2020-11-24 | 2020-11-24 | 一种采用高效液相色谱法测定肺炎球菌多糖-蛋白结合疫苗中dmap残留量的方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114544841A true CN114544841A (zh) | 2022-05-27 |
Family
ID=81659158
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011325866.1A Pending CN114544841A (zh) | 2020-11-24 | 2020-11-24 | 一种采用高效液相色谱法测定肺炎球菌多糖-蛋白结合疫苗中dmap残留量的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114544841A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114965784A (zh) * | 2022-06-01 | 2022-08-30 | 艾美探索者生命科学研发有限公司 | 多糖活化度的测定方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103830723A (zh) * | 2012-11-26 | 2014-06-04 | 天士力制药集团股份有限公司 | 一种肺炎链球菌荚膜多糖蛋白结合疫苗的制备方法 |
CN105301141A (zh) * | 2015-11-30 | 2016-02-03 | 北京成大天和生物科技有限公司 | 多糖结合疫苗中残余cdap的高效液相色谱检测方法 |
CN105891348A (zh) * | 2016-03-29 | 2016-08-24 | 山东省分析测试中心 | 抗生素类药物原料中毒性杂质dmap的检测方法 |
CN108267518A (zh) * | 2016-12-31 | 2018-07-10 | 天津金耀集团有限公司 | 一种醋酸阿比特龙中dmap含量的测定方法 |
WO2018169303A1 (ko) * | 2017-03-15 | 2018-09-20 | 주식회사 엘지화학 | 다가 폐렴구균 백신 조성물 |
CN109001198A (zh) * | 2018-09-03 | 2018-12-14 | 艾美卫信生物药业(浙江)有限公司 | 脱氧胆酸钠沉淀法检测Hib结合疫苗中游离多糖的方法 |
-
2020
- 2020-11-24 CN CN202011325866.1A patent/CN114544841A/zh active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103830723A (zh) * | 2012-11-26 | 2014-06-04 | 天士力制药集团股份有限公司 | 一种肺炎链球菌荚膜多糖蛋白结合疫苗的制备方法 |
CN105301141A (zh) * | 2015-11-30 | 2016-02-03 | 北京成大天和生物科技有限公司 | 多糖结合疫苗中残余cdap的高效液相色谱检测方法 |
CN105891348A (zh) * | 2016-03-29 | 2016-08-24 | 山东省分析测试中心 | 抗生素类药物原料中毒性杂质dmap的检测方法 |
CN108267518A (zh) * | 2016-12-31 | 2018-07-10 | 天津金耀集团有限公司 | 一种醋酸阿比特龙中dmap含量的测定方法 |
WO2018169303A1 (ko) * | 2017-03-15 | 2018-09-20 | 주식회사 엘지화학 | 다가 폐렴구균 백신 조성물 |
CN109001198A (zh) * | 2018-09-03 | 2018-12-14 | 艾美卫信生物药业(浙江)有限公司 | 脱氧胆酸钠沉淀法检测Hib结合疫苗中游离多糖的方法 |
Non-Patent Citations (2)
Title |
---|
KATAKAM, PRAKASH ET AL: "An experimental design approach for impurity profiling of valacyclovir-related products by RP-HPLC", SCIENTIA PHARMACEUTICA, vol. 82, no. 3, 31 December 2014 (2014-12-31), pages 617 - 630 * |
王震;褚自青;刘晓磊;张景春;马宏初;孙述学;: "多糖结合疫苗中残余CDAP检测方法的建立及验证", 中国生物制品学杂志, no. 02, 31 December 2017 (2017-12-31), pages 95 - 97 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114965784A (zh) * | 2022-06-01 | 2022-08-30 | 艾美探索者生命科学研发有限公司 | 多糖活化度的测定方法 |
CN114965784B (zh) * | 2022-06-01 | 2023-10-27 | 艾美探索者生命科学研发有限公司 | 多糖活化度的测定方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101963604B (zh) | 烟草中甾醇的测定方法 | |
Abbott et al. | Determination of morphine in body fluids by high-performance liquid chromatography with chemiluminescence detection | |
CN105891357A (zh) | 一种动态示踪监测动物体内烟碱及其代谢物的分析方法 | |
CN109030658B (zh) | 一种婴幼儿乳粉中低聚果糖和棉子糖的检测方法 | |
CN105136951A (zh) | 一种茶叶多糖单糖组成的快速定量方法 | |
CN113899836A (zh) | 土壤样品和沉积物样品中抗生素的快速高通量检测方法 | |
CN111855827A (zh) | 多糖蛋白结合疫苗中多糖蛋白结合位点结合率的测定方法 | |
CN103323562A (zh) | 一种主流烟气中水溶性糖含量的检测方法 | |
CN114544841A (zh) | 一种采用高效液相色谱法测定肺炎球菌多糖-蛋白结合疫苗中dmap残留量的方法 | |
CN110940746A (zh) | 一种分析肉桂多糖中单糖组成的测定方法 | |
Honour et al. | Mass spectrometric analysis for tetrahydroaldosterone | |
CN110632201A (zh) | 一种精确检测乳粉中低聚半乳糖含量的方法 | |
CN113433232B (zh) | 一种测定人参属中药中人参皂苷含量的方法 | |
KR101159064B1 (ko) | 동위원소 희석-질량분석법을 이용한 생체 시료 내 활성 남성호르몬의 정량방법 | |
CN112924563B (zh) | 一种基于衍生化的母乳寡糖表征和定量分析方法 | |
CN111307990B (zh) | 一种同时测定人工虎骨粉中胱氨酸和甲硫氨酸含量的方法 | |
Ding et al. | Determination of 5′-mononucleotides in infant formula by capillary electrophoresis with ultraviolet detection | |
Boppana et al. | High-performance liquid chromatographic determination of guanidino compounds by automated pre-column fluorescence derivatization | |
CN102243215A (zh) | 一种水溶性葡甘露聚糖的检测方法 | |
CN112964796A (zh) | 一种测定化妆品中牛胆酸的方法 | |
CN114577958B (zh) | 一种单糖的分析方法 | |
CN110632192A (zh) | 婴幼儿配方乳粉中低聚半乳糖含量的测定方法 | |
CN114200050B (zh) | 一种对溴苯甲醚中的有关物质含量的hplc检测方法 | |
CN111323492A (zh) | 一种复合色谱柱以及一种二维液相色谱系统 | |
CN114965784B (zh) | 多糖活化度的测定方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Li Shuanghua Inventor after: Tian Hongmin Inventor after: Chen Yu Inventor after: Dong Wei Inventor after: Li Hong Inventor after: Zhao Ping Inventor after: Xiang Hai Inventor before: Xiang Hai |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20230118 Address after: Building A9-2, Small and Medium Enterprises Park, Biomedical Industrial Park, No. 858, Gaoxin Avenue, Donghu High tech Zone, Wuhan City, 430206, Hubei Province Applicant after: BRAVOVAX Co.,Ltd. Address before: 411101 No. 1802016, block B, Wanda Plaza, 281 Xiangtan Avenue, high tech Zone, Xiangtan City, Hunan Province Applicant before: XIANGTAN ZHILIAN TECHNOLOGY MATASTASIS PROMOTE Co.,Ltd. |